Primrose Medical Inc

Form 483 issued October 26, 2022 · East Walpole, Massachusetts

Inspection
Oct 13 – Oct 26, 2022
Investigator
Sunita Pandey
Observations
11
Pages
8
FEI number
1220905

In short: On October 26, 2022, FDA issued a Form 483 with 11 observations to Primrose Medical Inc in East Walpole, Massachusetts (FEI 1220905) after an inspection that ran Oct 13 – Oct 26, 2022. The investigator was Sunita Pandey. Most observations concern design controls and cAPA; the most-cited regulation is 21 CFR 820.30 (design controls).

At a glance

Observations span 4 systems, led by design controls.

Design controls3
CAPA3
Production & process controls3
Management controls2

What FDA observed

Preview: the opening words of each observation
  1. 01

    The design history file does not demonstrate that the design was de’veloped following the requirements…

  2. 02

    Procedures for design control…

  3. 03

    Risk analysis was not…

  4. 04

    Procedmes for collective and preventive action have…

7 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Primrose Medical Inc?

FDA listed 11 observations on this Form 483, mostly about design controls, cAPA and production & process controls. The most-cited regulation is 21 CFR 820.30 (design controls). The opening words of each observation are shown on this page.

Who inspected Primrose Medical Inc?

Sunita Pandey is named on this Form 483, for the inspection of Oct 13 – Oct 26, 2022. Each investigator has a profile showing what they cite most.

When was Primrose Medical Inc inspected by FDA?

The inspection ran Oct 13 – Oct 26, 2022, and the Form 483 is dated October 26, 2022.

How do I get the full Form 483 for Primrose Medical Inc?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free